Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS) SHH
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In CNY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2545
First IPO Date
April 24, 2015
| Name | Title | Pay | Year Born |
| Ji Lang | Investor Relations Director | 0 | N/A |
| Lei Wang | Chief Financial Officer & Accounting Supervisor | 0 | 1981 |
| Xiuzhen Li | Deputy General Manager | 0 | 1980 |
| Tianzhu Li | Deputy General Manager | 0 | 1978 |
| Zhongfang Zhang | Board Secretary | 0 | 1985 |
| Jiujiang Yan | GM & Chairman | 0 | 1978 |
Heilongjiang ZBD Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm dedicated to the entire lifecycle of Traditional Chinese Medicine (TCM), from research and development to manufacturing and sales, exclusively within China. Its extensive product portfolio addresses a wide spectrum of health concerns, including conditions related to cardiovascular and cerebrovascular health, respiratory ailments, orthopedic issues, oncology, digestive disorders, anti-infective treatments, neuropsychiatric conditions, and genitourinary problems, among others. Established in 1996, the company maintains its headquarters in Hulin, China.